Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1796) 1796
humans (1785) 1785
life sciences & biomedicine (1756) 1756
antifungal agents - therapeutic use (1527) 1527
echinocandins (1037) 1037
echinocandins - therapeutic use (974) 974
lipopeptides (916) 916
male (835) 835
infectious diseases (799) 799
microbiology (748) 748
female (712) 712
pharmacology & pharmacy (704) 704
antifungal agents - pharmacology (589) 589
candidiasis - drug therapy (580) 580
biological and medical sciences (574) 574
medical sciences (559) 559
middle aged (526) 526
antifungal agents (521) 521
adult (490) 490
caspofungin (474) 474
pharmacology. drug treatments (426) 426
treatment outcome (416) 416
aged (401) 401
amphotericin b - therapeutic use (396) 396
echinocandins - pharmacology (395) 395
mycoses (394) 394
microbial sensitivity tests (389) 389
voriconazole (388) 388
animals (387) 387
antibiotics. antiinfectious agents. antiparasitic agents (379) 379
mycoses - drug therapy (374) 374
peptides, cyclic - therapeutic use (350) 350
antifungal agents - administration & dosage (346) 346
micafungin (345) 345
triazoles - therapeutic use (313) 313
aspergillosis - drug therapy (312) 312
drug therapy, combination (303) 303
lipopeptides - therapeutic use (291) 291
candida - drug effects (288) 288
mycology (283) 283
antifungal agents - adverse effects (274) 274
amphotericin b (273) 273
candidiasis - microbiology (270) 270
echinocandins - administration & dosage (262) 262
candidiasis (251) 251
drug resistance, fungal (245) 245
echinocandin (241) 241
antifungal agents - pharmacokinetics (240) 240
health aspects (231) 231
pyrimidines - therapeutic use (223) 223
fluconazole (221) 221
adolescent (217) 217
fluconazole - therapeutic use (209) 209
bacterial infections and mycoses (206) 206
candida (206) 206
aspergillosis (201) 201
drug therapy (201) 201
immunology (200) 200
fungal infections (199) 199
child (192) 192
echinocandins - adverse effects (191) 191
immunocompromised host (184) 184
mice (183) 183
anidulafungin (174) 174
fungi (170) 170
risk factors (170) 170
candidemia (167) 167
candida - isolation & purification (166) 166
care and treatment (166) 166
mortality (166) 166
retrospective studies (163) 163
echinocandins - pharmacokinetics (159) 159
infections (153) 153
young adult (153) 153
aged, 80 and over (152) 152
candida albicans - drug effects (151) 151
azoles (147) 147
transplantation (145) 145
amphotericin b - pharmacology (143) 143
peptides, cyclic (141) 141
analysis (140) 140
general & internal medicine (140) 140
internal medicine (137) 137
human mycoses (135) 135
medicine & public health (129) 129
research (128) 128
dermatology (126) 126
lipoproteins - therapeutic use (126) 126
pediatrics (125) 125
amphotericin b - administration & dosage (124) 124
fungemia - drug therapy (124) 124
child, preschool (118) 118
antifungals (117) 117
dosage and administration (116) 116
candidiasis, invasive - drug therapy (113) 113
infant, newborn (113) 113
peptides, cyclic - pharmacology (112) 112
candidemia - drug therapy (111) 111
drug interactions (111) 111
disease models, animal (110) 110
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2146) 2146
German (75) 75
Spanish (75) 75
Japanese (35) 35
French (30) 30
Chinese (12) 12
Portuguese (9) 9
Russian (5) 5
Turkish (5) 5
Dutch (2) 2
Danish (1) 1
Italian (1) 1
Norwegian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Candida auris and multidrug resistance: Defining the new normal
by Lockhart, Shawn R
Fungal genetics and biology, ISSN 1087-1845, 10/2019, Volume 131, pp. 103243 - 103243
Fluconazole - pharmacology | Tetrazoles - pharmacology | Humans | Azoles - therapeutic use | Drug Resistance, Multiple, Fungal - physiology | Candidiasis - microbiology | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Aminopyridines - therapeutic use | Candidiasis - drug therapy | 14-alpha Demethylase Inhibitors - therapeutic use | Echinocandins - pharmacology | Pyridines - therapeutic use | Antifungal Agents - pharmacology | Amphotericin B - pharmacology | Azoles - pharmacology | Isoxazoles - pharmacology | 14-alpha Demethylase Inhibitors - pharmacology | Aminopyridines - pharmacology | Echinocandins - therapeutic use | Tetrazoles - therapeutic use | Pyridines - pharmacology | Candida - drug effects | Isoxazoles - therapeutic use | Amphotericin B - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinically relevant drug-drug interactions between antiretrovirals and antifungals
by Vadlapatla, Ramya Krishna and Patel, Mitesh and Paturi, Durga K and Pal, Dhananjay and Mitra, Ashim K
Expert opinion on drug metabolism & toxicology, ISSN 1742-5255, 04/2014, Volume 10, Issue 4, pp. 561 - 580
opportunistic infections | antiretrovirals | human immunodeficiency virus infection | pharmacodynamic | pharmacokinetic | azole antifungals | therapeutic drug monitoring | clinical recommendations | Therapeutic drug monitoring | Antiretrovirals | Opportunistic infections | Human immunodeficiency virus infection | Pharmacodynamic | Azole antifungals | Clinical recommendations | Pharmacokinetic | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Toxicology | Life Sciences & Biomedicine | Science & Technology | Anti-Retroviral Agents - therapeutic use | Humans | AIDS-Related Opportunistic Infections - drug therapy | Organophosphates - therapeutic use | HIV Protease Inhibitors - therapeutic use | Antifungal Agents - therapeutic use | Benzoxazines - therapeutic use | Itraconazole - therapeutic use | Drug Interactions | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | HIV Infections - complications | Mycoses - drug therapy | Voriconazole | Echinocandins - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Mycoses - complications | Carbamates - therapeutic use | Drug Monitoring | Triazoles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents
by Nikolaos G. Almyroudis and Deanna A. Sutton and Annette W. Fothergill and Michael G. Rinaldi and Shimon Kusne
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2007, Volume 51, Issue 7, pp. 2587 - 2590
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Itraconazole - therapeutic use | Microbial Sensitivity Tests | Ketoconazole - therapeutic use | Pyrimidines - therapeutic use | Flucytosine - therapeutic use | Caspofungin | Voriconazole | Echinocandins | Peptides, Cyclic - therapeutic use | Amphotericin B - therapeutic use | In Vitro Techniques | Mucormycosis - drug therapy | Lipopeptides | Triazoles - therapeutic use | Index Medicus | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Drugs in Clinical Development for Fungal Infections
by Gonzalez-Lara, Maria F and Sifuentes-Osornio, Jose and Ostrosky-Zeichner, Luis
Drugs (New York, N.Y.), ISSN 0012-6667, 09/2017, Volume 77, Issue 14, pp. 1505 - 1518
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Polyenes - chemistry | Humans | Acetamides - pharmacology | Antibodies, Monoclonal - therapeutic use | Antifungal Agents - chemistry | Azoles - therapeutic use | Antifungal Agents - therapeutic use | Acetamides - therapeutic use | Polyenes - therapeutic use | Pyrroles - therapeutic use | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Antibodies, Monoclonal - pharmacology | Polyenes - pharmacology | Piperazines - therapeutic use | Pyrimidines - pharmacology | Azoles - pharmacology | Piperazines - pharmacology | Chemistry, Pharmaceutical | Azoles - chemistry | Pyrroles - pharmacology | Pyrimidines - therapeutic use | Mycoses - drug therapy | Echinocandins - therapeutic use | Drug Development | Drugs | Fungicides | Toxicity | Antibodies | Tetrazoles | Infections | Fungal infections | Drug development | Tropical diseases | Fungi | Glucan | Synthesis | Heterocyclic compounds | Polyenes | Meningitis | Immunoglobulins | Mortality | Oral administration | Chitin | Bioavailability | FDA approval | Meningoencephalitis | Azoles | Inhibitors | Amphotericin B | Monoclonal antibodies | Glycosylphosphatidylinositol | Mutation
Journal Article
Details down arrow
5. Full Text Recent Advances in the Management of Mucormycosis: From Bench to Bedside
by Brad Spellberg and Thomas J. Walsh and Dimitrios P. Kontoyiannis and John Edwards and Ashraf S. Ibrahim
Clinical infectious diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1743 - 1751
Antifungals | Mucormycosis | Granulocytes | Clinical Practice | Lipids | Infections | Mice | Fungal infections | Diabetes | Dosage | Zygomycosis | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Benzoates - therapeutic use | Mucormycosis - diagnosis | Humans | Clinical Trials as Topic | Antifungal Agents - therapeutic use | Case Management | Polyenes - therapeutic use | Echinocandins - therapeutic use | Amphotericin B - therapeutic use | Drug Therapy, Combination | Mucormycosis - drug therapy | Immunologic Factors - therapeutic use | Triazoles - therapeutic use | Clinical trials | Therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Breaking the Mold
: A Review of Mucormycosis and Current Pharmacological Treatment Options
by Riley, Treavor T and Muzny, Christina A and Swiatlo, Edwin and Legendre, Davey P
9/2016, Volume 50, Issue 9, 11
posaconazole | Mucorales | isavuconazole | amphotericin B | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Mucorales - isolation & purification | Lipopeptides - therapeutic use | Humans | Middle Aged | Virulence | Male | Mucorales - pathogenicity | Antifungal Agents - therapeutic use | Mucorales - classification | Echinocandins - administration & dosage | Nitriles - administration & dosage | Pyridines - adverse effects | Amphotericin B - administration & dosage | Mucormycosis - drug therapy | Drug Resistance, Fungal | Pyridines - therapeutic use | Triazoles - therapeutic use | Pyridines - administration & dosage | Mucorales - drug effects | Amphotericin B - adverse effects | Debridement | Echinocandins - adverse effects | Mucormycosis - microbiology | Lipopeptides - adverse effects | Echinocandins - therapeutic use | Lipopeptides - administration & dosage | Amphotericin B - therapeutic use | Nitriles - adverse effects | Antifungal Agents - administration & dosage | Nitriles - therapeutic use | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
7. New lead structures in antifungal drug discovery
by Sheng, Chunquan and Zhang, Wannian
Current medicinal chemistry, ISSN 0929-8673, 02/2011, Volume 18, Issue 5, pp. 733 - 766
Antifungal | Lead compounds | Structure-activity relationship | Rational drug design | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Glucosyltransferases - antagonists & inhibitors | Humans | Sterol 14-Demethylase - therapeutic use | Naphthoquinones - therapeutic use | Structure-Activity Relationship | Drug Discovery | Enzyme Inhibitors - therapeutic use | Antifungal Agents - therapeutic use | Mycoses - drug therapy | Echinocandins - therapeutic use | Carbazoles - therapeutic use | 14-alpha Demethylase Inhibitors - therapeutic use | Triazoles - therapeutic use | Infection | Drug discovery | Pharmacokinetics | Toxicity | Antifungal agents | Index Medicus
Journal Article
Details down arrow
8. Full Text Spondylodiscitis Due to Aspergillus terreus in an Immunocompetent Host: Case Report and Literature Review
by Comacle, Pauline and Le Govic, Yohann and Hoche-Delchet, Cyril and Sandrini, Jeremy and Aguilar, Claire and Bouyer, Benjamin and Blanchi, Sophie and Penn, Pascale
Mycopathologia (1975), ISSN 0301-486X, 8/2016, Volume 181, Issue 7, pp. 575 - 581
Life Sciences | Antifungals | Medical Microbiology | Microbial Ecology | Microbiology | Spondylodiscitis | Aspergillosis | Vertebral osteomyelitis | Aspergillus terreus | Immunocompetent | Plant Sciences | Eukaryotic Microbiology | Life Sciences & Biomedicine | Mycology | Science & Technology | Aspergillus - classification | Discitis - drug therapy | Lipopeptides - therapeutic use | Humans | Discitis - pathology | Aspergillosis - diagnosis | Male | Antifungal Agents - therapeutic use | Tuberculosis, Pulmonary - complications | Young Adult | Aspergillosis - pathology | Aspergillus - isolation & purification | Spine - pathology | Aspergillosis - drug therapy | Voriconazole - therapeutic use | Magnetic Resonance Imaging | Spine - diagnostic imaging | Microscopy | Biopsy | Spine - microbiology | Aspergillosis - microbiology | Histocytochemistry | Echinocandins - therapeutic use | Discitis - etiology | Microbiological Techniques | Discitis - microbiology | Infection | Care and treatment | Immunotherapy | HIV testing | Mycoses | Backache | Health aspects | Index Medicus | Spine/pathology | Lipopeptides/therapeutic use | Discitis/pathology | Aspergillosis/drug therapy | Aspergillus/isolation & purification | Caspofungin | Echinocandins/therapeutic use | Spine/microbiology | Voriconazole/therapeutic use | Discitis/microbiology | Aspergillosis/diagnosis | Discitis/etiology | Aspergillus/classification | Spine/diagnostic imaging | Microbiology and Parasitology | Aspergillosis/pathology | Aspergillosis/microbiology | Discitis/drug therapy | Antifungal Agents/therapeutic use | Tuberculosis, Pulmonary/complications
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights